Revealing binding selectivity of inhibitors toward bromodomain-containing proteins 2 and 4 using multiple short molecular dynamics simulations and free energy analyses

References

• T. Noguchi-Yachide, BET bromodomain as a target of epigenetic therapy, Chem. Pharm. Bull. 64 (2016), pp. 540–547. doi:10.1248/cpb.c16-00225.
   PubMed Web of Science ®Google Scholar
• S.G. Smith and M.-M. Zhou, The bromodomain: A new target in emerging epigenetic medicine, ACS Chem. Biol. 11 (2016), pp. 598–608. doi:10.1021/acschembio.5b00831.
   PubMed Web of Science ®Google Scholar
• R. Sanchez, J. Meslamani, and M.-M. Zhou, The bromodomain: From epigenome reader to druggable target, BBA-Gene Regul. Mech. 1839 (2014), pp. 676–685.
   Google Scholar
• S. Mujtaba, L. Zeng, and M.M. Zhou, Structure and acetyl-lysine recognition of the bromodomain, Oncogene 26 (2007), pp. 5521–5527. doi:10.1038/sj.onc.1210618.
   PubMed Web of Science ®Google Scholar
• X. Lucas, D. Wohlwend, M. Hügle, K. Schmidtkunz, S. Gerhardt, R. Schüle, M. Jung, O. Einsle, and S. Günther, 4-Acyl pyrroles: Mimicking acetylated lysines in histone code reading, Angew. Chem. Int. Edit. 52 (2013), pp. 14055–14059. doi:10.1002/anie.201307652.
   PubMed Web of Science ®Google Scholar
• T.D. Crawford, V. Tsui, E.M. Flynn, S. Wang, A. M. Taylor, A. Côté, J.E. Audia, M.H. Beresini, D.J. Burdick, R.T. Cummings, L.A. Dakin, M. Duplessis, A.C. Good, M.C. Hewitt, H.R. Huang, H. Jayaram, J.R. Kiefer, Y. Jiang, J. Murray, C.G. Nasveschuk, E. Pardo, F. Poy, F.A. Romero, Y. Tang, J. Wang, Z. Xu, L.E. Zawadzke, X. Zhu, B.K. Albrecht, S.R. Magnuson, S. Bellon, and A.G. Cochran, Diving into the water: Inducible binding conformations for BRD4, TAF1(2), BRD9, and CECR2 bromodomains, J. Med. Chem. 59 (2016), pp. 5391–5402. doi:10.1021/acs.jmedchem.6b00264.
   PubMed Web of Science ®Google Scholar
• H. Zhong, Z. Wang, X. Wang, H. Liu, D. Li, H. Liu, X. Yao, and T. Hou, Importance of a crystalline water network in docking-based virtual screening: A case study of BRD4, Phys. Chem. Chem. Phys. 21 (2019), pp. 25276–25289. doi:10.1039/C9CP04290C.
   PubMed Web of Science ®Google Scholar
• Y. Rodríguez, G. Gerona‐Navarro, R. Osman, and M.M. Zhou, In silico design and molecular basis for the selectivity of olinone toward the first over the second bromodomain of BRD4, Proteins 88 (2020), pp. 414–430.
   PubMed Web of Science ®Google Scholar
• E. Nittinger, P. Gibbons, C. Eigenbrot, D.R. Davies, B. Maurer, C.L. Yu, J.R. Kiefer, A. Kuglstatter, J. Murray, and D.F. Ortwine, Water molecules in protein–ligand interfaces. Evaluation of software tools and SAR comparison, J. Comput. Aid. Mol. Des. 33 (2019), pp. 307–330. doi:10.1007/s10822-019-00187-y.
   PubMed Web of Science ®Google Scholar
• R.G. Bryant, The dynamics of water-protein interaction, Annu. Rev. Bioph. Biom. 25 (1996), pp. 29–53. doi:10.1146/annurev.bb.25.060196.000333.
   PubMedGoogle Scholar
• V.P. Denisov and B. Halle, Protein hydration dynamics in aqueous solution, Farad. Disc. 103 (1996), pp. 227–244. doi:10.1039/fd9960300227.
   PubMed Web of Science ®Google Scholar
• E. Meyer, Internal water molecules and H-bonding in biological macromolecules: A review of structural features with functional implications, Protein Sci. 1 (1992), pp. 1543–1562. doi:10.1002/pro.5560011203.
   PubMed Web of Science ®Google Scholar
• A. Speck-Planche and M.T. Scotti, BET bromodomain inhibitors: Fragment-based in silico design using multi-target QSAR models, Mol. Divers. 23 (2019), pp. 555–572. doi:10.1007/s11030-018-9890-8.
   PubMed Web of Science ®Google Scholar
• E. Bourova-Flin, F. Chuffart, S. Rousseaux, and S. Khochbin, The role of bromodomain testis-specific factor, BRDT, in cancer: A biomarker and a possible therapeutic target, Cell J. 19 (2017), pp. 1–8. doi:10.22074/cellj.2017.5060.
   PubMed Web of Science ®Google Scholar
• H. Huang, Y. Wang, Q. Li, X. Fei, H. Ma, and R. Hu, miR-140-3p Functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9, Cancer Lett. 446 (2019), pp. 81–89. doi:10.1016/j.canlet.2019.01.007.
   PubMed Web of Science ®Google Scholar
• R.M. Karim and E. Schönbrunn, An advanced tool to interrogate BRD9, J. Med. Chem. 59 (2016), pp. 4459–4461. doi:10.1021/acs.jmedchem.6b00550.
   PubMed Web of Science ®Google Scholar
• D.A. Hay, C.M. Rogers, O. Fedorov, C. Tallant, S. Martin, O.P. Monteiro, S. Müller, S. Knapp, C.J. Schofield, and P.E. Brennan, Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains, Med. Chem. Comm. 6 (2015), pp. 1381–1386. doi:10.1039/C5MD00152H.
   Google Scholar
• A. Halder and A. Giri, Multi-target chemometric modelling, fragment analysis and virtual screening with ERK Inhibitors as potential anticancer agents, Molecules 24 (2019), pp. 3909. doi:10.3390/molecules24213909.
   Web of Science ®Google Scholar
• T. Zhu, X. He, and J.Z.H. Zhang, Fragment density functional theory calculation of NMR chemical shifts for proteins with implicit solvation, Phys Chem. Chem. Phys. 14 (2012), pp. 7837–7845. doi:10.1039/C2CP23746F.
   PubMed Web of Science ®Google Scholar
• A. Speck-Planche, Combining ensemble learning with a fragment-based topological approach to generate new molecular diversity in drug discovery: In silico design of Hsp90 inhibitors, ACS Omega 3 (2018), pp. 14704–14716. doi:10.1021/acsomega.8b02419.
   PubMed Web of Science ®Google Scholar
• F.J. Romero-Durán, N. Alonso, M. Yañez, O. Caamaño, X. García-Mera, and H. González-Díaz, Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives, Neuropharmacology 103 (2016), pp. 270–278. doi:10.1016/j.neuropharm.2015.12.019.
   PubMed Web of Science ®Google Scholar
• M. Brand, A.M. Measures, B.G. Wilson, W.A. Cortopassi, R. Alexander, M. Höss, D.S. Hewings, T.P.C. Rooney, R.S. Paton, and S.J. Conway, Small molecule inhibitors of bromodomain–acetyl-lysine interactions, ACS Chem. Biol. 10 (2015), pp. 22–39. doi:10.1021/cb500996u.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos and S. Knapp, Targeting bromodomains: Epigenetic readers of lysine acetylation, Nat. Rev. Drug Discov. 13 (2014), pp. 337–356. doi:10.1038/nrd4286.
   PubMed Web of Science ®Google Scholar
• P. Rajendran, G.S. Johnson, L. Li, Y.-S. Chen, W.M. Dashwood, N. Nguyen, A.M. Ulusan, F.U. Ertem, M. Zhang, and J. Li, Acetylation of CCAR2 establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition, Cancer Res. 79 (2019), pp. 918–927. doi:10.1158/0008-5472.CAN-18-2003.
   PubMedGoogle Scholar
• Z. Zhang, S. Hou, H. Chen, T. Ran, F. Jiang, Y. Bian, D. Zhang, Y. Zhi, L. Wang, L. Zhang, H. Li, Y. Zhang, W. Tang, T. Lu, and Y. Chen, Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors, Bioorg. Med. Chem. Lett. 26 (2016), pp. 2931–2935. doi:10.1016/j.bmcl.2016.04.034.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations, Chem. Bio. Drug Des. 91 (2017), pp. 828–840. doi:10.1111/cbdd.13148.
   PubMed Web of Science ®Google Scholar
• C.M. Chiang, Brd4 engagement from chromatin targeting to transcriptional regulation: Selective contact with acetylated histone H3 and H4, F1000 Biol. Rep. 1 (2009), pp. 98.
   PubMedGoogle Scholar
• G.A. Josling, S.A. Selvarajah, M. Petter, and M.F. Duffy, The role of bromodomain proteins in regulating gene expression, Genes 3 (2012), pp. 320–343. doi:10.3390/genes3020320.
   PubMed Web of Science ®Google Scholar
• R. Sanchez and M.-M. Zhou, The role of human bromodomains in chromatin biology and gene transcription, Curr. Opin. Drug Disc. Dev. 12 (2009), pp. 659–665.
   PubMedGoogle Scholar
• M.G.J. Baud, E. Lin-Shiao, T. Cardote, C. Tallant, A. Pschibul, K.-H. Chan, M. Zengerle, J.R. Garcia, T.T.-L. Kwan, and F.M. Ferguson, A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes, Science 346 (2014), pp. 638–641. doi:10.1126/science.1249830.
   PubMed Web of Science ®Google Scholar
• Q. Wang, Y. Li, J. Xu, Y. Wang, E.L.-H. Leung, L. Liu, and X. Yao, Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: Insight from microsecond molecular dynamics simulations, Sci. Rep. 7 (2017), pp. 8857. doi:10.1038/s41598-017-08909-8.
   PubMed Web of Science ®Google Scholar
• Q. Wang, Y. Li, J. Xu, Y. Wang, D. Shi, L. Liu, E.L.-H. Leung, and X. Yao, Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4, Proteins 87 (2019), pp. 3–11. doi:10.1002/prot.25611.
   PubMed Web of Science ®Google Scholar
• R. Tumdam, A. Kumar, N. Subbarao, and B.S. Balaji, In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD, SAR QSAR Environ. Res. 29 (2018), pp. 975–996. doi:10.1080/1062936X.2018.1537301.
   PubMed Web of Science ®Google Scholar
• C.M. Chiang, Brd4 engagement from chromatin targeting to transcriptional regulation: Selective contact with acetylated histone H3 and H4, F1000 Biol. Rep. 1 (2009), pp. 98.
   PubMedGoogle Scholar
• V. Deepak, B. Wang, D. Koot, A. Kasonga, X.X. Stander, M. Coetzee, and A. Stander, In silico design and bioevaluation of selective benzotriazepine BRD4 inhibitors with potent antiosteoclastogenic activity, Chem. Biol. Drug Des. 90 (2017), pp. 97–111. doi:10.1111/cbdd.12930.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W.B. Smith, O. Fedorov, E.M. Morse, T. Keates, T.T. Hickman, I. Felletar, M. Philpott, S. Munro, M.R. McKeown, Y. Wang, A.L. Christie, N. West, M.J. Cameron, B. Schwartz, T.D. Heightman, N. La Thangue, C.A. French, O. Wiest, A.L. Kung, S. Knapp, and J.E. Bradner, Selective inhibition of BET bromodomains, Nature 468 (2010), pp. 1067–1073. doi:10.1038/nature09504.
   PubMed Web of Science ®Google Scholar
• E. Nicodeme, K.L. Jeffrey, U. Schaefer, S. Beinke, S. Dewell, C.-W. Chung, R. Chandwani, I. Marazzi, P. Wilson, and H. Coste, Suppression of inflammation by a synthetic histone mimic, Nature 468 (2010), pp. 1119–1123. doi:10.1038/nature09589.
   PubMed Web of Science ®Google Scholar
• E.L. Wu, K.-Y. Wong, X. Zhang, K. Han, and J. Gao, Determination of the structure form of the fourth ligand of zinc in acutolysin a using combined quantum mechanical and molecular mechanical simulation, J. Phys. Chem. B 113 (2009), pp. 2477–2485. doi:10.1021/jp808182y.
   PubMed Web of Science ®Google Scholar
• L. Wang, Y. Wang, H. Sun, J. Zhao, and Q. Wang, Theoretical insight into molecular mechanisms of inhibitor bindings to bromodomain-containing protein 4 using molecular dynamics simulations and calculations of binding free energies, Chem. Phys. Lett. 736 (2019), pp. 136785. doi:10.1016/j.cplett.2019.136785.
   Web of Science ®Google Scholar
• K. Wittayanarakul, O. Aruksakunwong, S. Saen-oon, W. Chantratita, V. Parasuk, P. Sompornpisut, and S. Hannongbua, Insights into saquinavir resistance in the G48V HIV-1 protease: Quantum calculations and molecular dynamic simulations, Biophys. J. 88 (2005), pp. 867–879. doi:10.1529/biophysj.104.046110.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, L. Pang, J.Z.H. Zhang, and T. Zhu, Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations, Nucleic Acids Res. 47 (2019), pp. 6618–6631. doi:10.1093/nar/gkz499.
   PubMed Web of Science ®Google Scholar
• L. Duan, G. Feng, X. Wang, L. Wang, and Q. Zhang, Effect of electrostatic polarization and bridging water on CDK2–ligand binding affinities calculated using a highly efficient interaction entropy method, Phys. Chem. Che. Phys. 19 (2017), pp. 10140–10152. doi:10.1039/C7CP00841D.
   PubMed Web of Science ®Google Scholar
• L. Duan, X. Liu, and J.Z.H. Zhang, Interaction entropy: A new paradigm for highly efficient and reliable computation of protein–ligand binding free energy, J. Am. Chem. Soc. 138 (2016), pp. 5722–5728. doi:10.1021/jacs.6b02682.
   PubMed Web of Science ®Google Scholar
• L. Wang, G. Zheng, X. Liu, D. Ni, X. He, J. Cheng, and S. Lu, Molecular dynamics simulations provide insights into the origin of gleevec’s selectivity toward human tyrosine kinases, J. Biomol. Struct. Dyn. 37 (2019), pp. 2733–2744. doi:10.1080/07391102.2018.1496139.
   PubMed Web of Science ®Google Scholar
• A. Bunker, P.T. Männistö, J.-F.S. Pierre, T. Róg, P. Pomorski, L. Stimson, and M. Karttunen, Molecular dynamics simulations of the enzyme Catechol-O-Methyltransferase: Methodological issues, SAR QSAR Environ. Res. 19 (2008), pp. 179–189. doi:10.1080/10629360701843318.
   PubMed Web of Science ®Google Scholar
• M.A. Azam, S. Jupudi, N. Saha, and R.K. Paul, Combining molecular docking and molecular dynamics studies for modelling Staphylococcus aureus MurD inhibitory activity, SAR QSAR Environ. Res. 30 (2019), pp. 1–20. doi:10.1080/1062936X.2018.1539034.
   PubMed Web of Science ®Google Scholar
• P.K. Singh and O. Silakari, Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC, SAR QSAR Environ. Res. 28 (2017), pp. 221–233. doi:10.1080/1062936X.2017.1300189.
   PubMed Web of Science ®Google Scholar
• J. Zhao, B. Yin, H. Sun, L. Pang, and J. Chen, Identifying hot spots of inhibitor-CDK2 bindings by computational alanine scanning, Chem. Phys. Lett. 747 (2020), pp. 137329. doi:10.1016/j.cplett.2020.137329.
   Web of Science ®Google Scholar
• P. Auffinger and E. Westhof, RNA hydration: Three nanoseconds of multiple molecular dynamics simulations of the solvated tRNA Asp anticodon hairpin, J. Mol. Biol. 269 (1997), pp. 326–341. doi:10.1006/jmbi.1997.1022.
   PubMed Web of Science ®Google Scholar
• L.S.D. Caves, J.D. Evanseck, and M. Karplus, Locally accessible conformations of proteins: Multiple molecular dynamics simulations of crambin, Protein Sci. 7 (1998), pp. 649–666. doi:10.1002/pro.5560070314.
   PubMed Web of Science ®Google Scholar
• B. Knapp, L. Ospina, and C.M. Deane, Avoiding false positive conclusions in molecular simulation: The importance of replicas, J. Chem. Theory Comput. 14 (2018), pp. 6127–6138. doi:10.1021/acs.jctc.8b00391.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, B. Yin, L. Pang, W. Wang, and W. Zhu, Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free-energy predictions, ACS Chem. Neurosci. 10 (2019), pp. 4303–4318. doi:10.1021/acschemneuro.9b00348.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Liu, S. Zhang, J. Chen, H. Sun, L. Zhang, and Q. Zhang, Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses, Phys. Chem. Chem. Phys. 22 (2020), pp. 2262–2275. doi:10.1039/C9CP05704H.
   PubMed Web of Science ®Google Scholar
• J. Chen, B. Yin, L. Pang, W. Wang, J.Z.H. Zhang, and T. Zhu, Binding modes and conformational changes of FK506-binding protein 51 induced by inhibitor bindings: Insight into molecular mechanisms based on multiple simulation technologies, J. Biomol. Struct. Dyn. 38 (2019), pp. 1–15.
   Web of Science ®Google Scholar
• S. Tian, J. Zeng, X. Liu, J. Chen, J.Z.H. Zhang, and T. Zhu, Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling, Phys. Chem. Chem. Phys. 21 (2019), pp. 22103–22112. doi:10.1039/C9CP03598B.
   PubMed Web of Science ®Google Scholar
• L. Wang, J.K. Pratt, T. Soltwedel, G.S. Sheppard, S.D. Fidanze, D. Liu, L.A. Hasvold, R.A. Mantei, J.H. Holms, W.J. McClellan, M.D. Wendt, C. Wada, R. Frey, T.M. Hansen, R. Hubbard, C.H. Park, L. Li, T.J. Magoc, D.H. Albert, X. Lin, S.E. Warder, P. Kovar, X. Huang, D. Wilcox, R. Wang, G. Rajaraman, A.M. Petros, C.W. Hutchins, S.C. Panchal, C. Sun, S.W. Elmore, Y. Shen, W.M. Kati, and K.F. McDaniel, Fragment-based, structure-enabled discovery of novel pyridones and pyridone macrocycles as potent bromodomain and extra-terminal domain (BET) Family bromodomain inhibitors, J. Med. Chem. 60 (2017), pp. 3828–3850. doi:10.1021/acs.jmedchem.7b00017.
   PubMed Web of Science ®Google Scholar
• W.L. DeLano, The PyMOL molecular graphics system. (2002). Available at http://www.pymol.org.
   Google Scholar
• J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:10.1002/jcc.20035.
   PubMed Web of Science ®Google Scholar
• J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:10.1021/acs.jctc.5b00255.
   PubMed Web of Science ®Google Scholar
• W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:10.1063/1.445869.
   Web of Science ®Google Scholar
• J.-P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes, J. Comput. Phys. 23 (1977), pp. 327–341. doi:10.1016/0021-9991(77)90098-5.
   Web of Science ®Google Scholar
• J.A. Izaguirre, D.P. Catarello, J.M. Wozniak, and R.D. Skeel, Langevin stabilization of molecular dynamics, J. Chem. Phys. 114 (2001), pp. 2090–2098. doi:10.1063/1.1332996.
   Web of Science ®Google Scholar
• T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N ⋅log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:10.1063/1.464397.
   Web of Science ®Google Scholar
• U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995), pp. 8577–8593. doi:10.1063/1.470117.
   Web of Science ®Google Scholar
• S. Le Grand, A.W. Götz, and R.C. Walker, SPFP: Speed without compromise—A mixed precision model for GPU accelerated molecular dynamics simulations, Comp. Phys. Commun. 3 (2012), pp. 374–380. doi:10.1016/j.cpc.2012.09.022.
   Google Scholar
• R. Salomon-Ferrer, A.W. Götz, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with aMBER on GPUs. 2. Explicit solvent particle mesh Ewald, J. Chem. Theory Comput. 9 (2013), pp. 3878–3888. doi:10.1021/ct400314y.
   PubMed Web of Science ®Google Scholar
• A.W. Götz, M.J. Williamson, D. Xu, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born, J. Chem. Theory Comput. 8 (2012), pp. 1542–1555. doi:10.1021/ct200909j.
   PubMed Web of Science ®Google Scholar
• Y. Miao, W. Sinko, L. Pierce, D. Bucher, R.C. Walker, and J.A. McCammon, Improved reweighting of accelerated molecular dynamics simulations for free energy calculation, J. Chem. Theory Comput. 10 (2014), pp. 2677–2689. doi:10.1021/ct500090q.
   PubMed Web of Science ®Google Scholar
• J. Wang, P. Morin, W. Wang, and P.A. Kollman, Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA, J. Am. Chem. Soc. 123 (2001), pp. 5221–5230. doi:10.1021/ja003834q.
   PubMed Web of Science ®Google Scholar
• C. Wang, D.A. Greene, L. Xiao, R. Qi, and R. Luo, Recent developments and applications of the MMPBSA method, Front. Mol. Biosci. 4 (2018), pp. 1–18. doi:10.3389/fmolb.2017.00087.
   Web of Science ®Google Scholar
• T. Hou, J. Wang, Y. Li, and W. Wang, Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking, J. Comput. Chem. 32 (2011), pp. 866–877. doi:10.1002/jcc.21666.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, T. Zhu, Q. Zhang, and J.Z.H. Zhang, A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods, J. Chem. Inf. Model. 55 (2015), pp. 1903–1913.
   PubMed Web of Science ®Google Scholar
• U. Raj, H. Kumar, and P.K. Varadwaj, Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors, J. Biomol. Struct. Dyn. 35 (2017), pp. 2351–2362. doi:10.1080/07391102.2016.1217276.
   PubMed Web of Science ®Google Scholar
• L.T. Song, J. Tu, R.R. Liu, M. Zhu, Y.J. Meng, and H.L. Zhai, Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations, J. Biomol. Struct. Dyn. 37 (2019), pp. 2970–2979. doi:10.1080/07391102.2018.1502097.
   PubMed Web of Science ®Google Scholar
• J. Wang, Q. Shao, B.P. Cossins, J. Shi, K. Chen, and W. Zhu, Thermodynamics calculation of protein–ligand interactions by QM/MM polarizable charge parameters, J. Biomol. Struct. Dyn. 34 (2016), pp. 163–176. doi:10.1080/07391102.2015.1019928.
   PubMed Web of Science ®Google Scholar
• T. Hou, N. Li, Y. Li, and W. Wang, Characterization of domain–peptide interaction interface: Prediction of SH3 domain-mediated protein–protein interaction network in yeast by generic structure-based models, J. Proteome Res. 11 (2012), pp. 2982–2995. doi:10.1021/pr3000688.
   PubMed Web of Science ®Google Scholar
• S. Genheden and U. Ryde, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opin. Drug Dis. 10 (2015), pp. 449–461. doi:10.1517/17460441.2015.1032936.
   PubMed Web of Science ®Google Scholar
• F. Yan, X. Liu, S. Zhang, Q. Zhang, and J. Chen, Understanding conformational diversity of heat shock protein 90 (HSP90) and binding features of inhibitors to HSP90 via molecular dynamics simulations, Chem. Biol. Drug Des. 95 (2020), pp. 87–103. doi:10.1111/cbdd.13623.
   PubMed Web of Science ®Google Scholar
• Y. Gao, T. Zhu, and J. Chen, Exploring drug-resistant mechanisms of I84V mutation in HIV-1 protease toward different inhibitors by thermodynamics integration and solvated interaction energy method, Chem. Phys. Lett. 706 (2018), pp. 400–408.
   Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations, J. Biomol. Struct. Dyn. 36 (2018), pp. 1212–1224. doi:10.1080/07391102.2017.1317666.
   PubMed Web of Science ®Google Scholar
• H. Sun, Y. Li, M. Shen, S. Tian, L. Xu, P. Pan, Y. Guan, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring, Phys. Chem. Chem. Phys. 16 (2014), pp. 22035–22045.doi:10.1039/c4cp03179b.
   PubMed Web of Science ®Google Scholar
• A. Onufriev, D. Bashford, and D.A. Case, Exploring protein native states and large-scale conformational changes with a modified generalized born model, Proteins 55 (2004), pp. 383–394.doi:10.1002/prot.20033.
   PubMed Web of Science ®Google Scholar
• X. Jiang, G. Chen, and L. Wang, Structural and dynamic evolution of the amphipathic N-terminus diversifies enzyme thermostability in the glycoside hydrolase family 12, Phys. Chem. Chem. Phys. 18 (2016), pp. 21340–21350. doi:10.1039/c6cp02998a.
   PubMed Web of Science ®Google Scholar
• B.R. Miller, T.D. McGee, J.M. Swails, N. Homeyer, H. Gohlke, and A.E. Roitberg, MMPBSA.py: An efficient program for end-state free energy calculations, J. Chem. Theory Comput. 8 (2012), pp. 3314–3321. doi:10.1021/ct300418h.
   PubMed Web of Science ®Google Scholar
• D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095.doi:10.1021/ct400341p.
   PubMed Web of Science ®Google Scholar
• S. Shi, K. Sui, W. Liu, Y. Lei, S. Zhang, and Q. Zhang, Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations, J. Biomol. Struct. Dyn. (2019), pp. 1–14. doi:10.1080/07391102.2019.1695671.
   Web of Science ®Google Scholar
• X. Jiang, W. Li, G. Chen, and L. Wang, Dynamic perturbation of the active site determines reversible thermal inactivation in glycoside hydrolase family 12, J. Chem. Inf. Model. 57 (2017), pp. 288–297. doi:10.1021/acs.jcim.6b00692.
   PubMed Web of Science ®Google Scholar
• M.T. Khan, A.U. Rehaman, M. Junaid, S.I. Malik, and D.-Q. Wei, Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance, Comput. Struct. Biotec. 16 (2018), pp. 379–387. doi:10.1016/j.csbj.2018.09.004.
   PubMed Web of Science ®Google Scholar
• F. Yan, X. Liu, S. Zhang, J. Su, Q. Zhang, and J. Chen, Electrostatic interaction-mediated conformational changes of adipocyte fatty acid binding protein probed by molecular dynamics simulation, J. Biomol. Struct. Dyn. 37 (2019), pp. 3583–3595. doi:10.1080/07391102.2018.1520648.
   PubMed Web of Science ®Google Scholar
• L.Q. Yang, P. Sang, R.-P. Zhang, and S.-Q. Liu, Substrate-induced changes in dynamics and molecular motions of cuticle-degrading serine protease PL646: A molecular dynamics study, RSC Adv. 7 (2017), pp. 42094–42104.
   Web of Science ®Google Scholar
• Y. Wang, L.F. Wang, L.L. Zhang, H.B. Sun, and J. Zhao, Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies, SAR QSAR Environ. Res. 31 (2019), pp. 149–170. doi:10.1080/1062936X.2019.1701075.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations, Chem. Biol. Drug Des. 93 (2019), pp. 163–176. doi:10.1111/cbdd.13398.
   PubMed Web of Science ®Google Scholar
• T. Ichiye and M. Karplus, Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins 11 (1991), pp. 205–217. doi:10.1002/prot.340110305.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, and W. Zhu, Zinc ion-induced conformational changes in new Delphi metallo-β-lactamase 1 probed by molecular dynamics simulations and umbrella sampling, Phys Chem. Chem. Phys. 19 (2017), pp. 3067–3075. doi:10.1039/c6cp08105c.
   PubMed Web of Science ®Google Scholar
• R.M. Levy, A.R. Srinivasan, W.K. Olson, and J.A. McCammon, Quasi-harmonic method for studying very low frequency modes in proteins, Biopolymers 23 (1984), pp. 1099–1112. doi:10.1002/bip.360230610.
   PubMed Web of Science ®Google Scholar
• W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. Model. 14 (1996), pp. 33–38.
   Web of Science ®Google Scholar
• M. Yang, X. Zhang, and K. Han, Molecular dynamics simulation of SRP GTPases: Towards an understanding of the complex formation from equilibrium fluctuations, Proteins 78 (2010), pp. 2222–2237. doi:10.1002/prot.22734.
   PubMed Web of Science ®Google Scholar
• J. Xing, W. Lu, R. Liu, Y. Wang, Y. Xie, H. Zhang, Z. Shi, H. Jiang, Y.-C. Liu, K. Chen, H. Jiang, C. Luo, and M. Zheng, Machine-learning-assisted approach for discovering novel inhibitors targeting bromodomain-containing protein 4, J. Chem. Inf. Model. 57 (2017), pp. 1677–1690. doi:10.1021/acs.jcim.7b00098.
   PubMed Web of Science ®Google Scholar